PTCE Pharmacy Connect | Pharmacy Times
PTCE Pharmacy Connect is a continuing education podcast for pharmacists, produced by Pharmacy Times. It offers free educational content created by pharmacists for pharmacists, covering various topics in pharmacy practice. The podcast aims to help pharmacists stay updated with the latest developments in the field.
Episodes
Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient | PTCE Pharmacy Connect
Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.
Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patie
The Latest Updates and Pharmacist Perspectives on RET Inhibitors in Non-Small Cell Lung Cancer | PTCE Pharmacy Connect
Educational Objectives
Review recent clinical updates of RET inhibitors and how they fit into the treatment paradigm for non‒small cell lung cancer
Identify and manage adverse effects of RET inhibitors to ensure patient safety and improve adherence
Faculty
Lauren Ledbetter, PharmD, BCOP
Clinical Pharmacy Specialist, Thoracic Medical Oncology
The James Cancer Hospital at The Ohio State Universit
Alleviating Patient Burden in Acne: Utilizing Ceramides to Address Skin Barrier Dysfunction | PTCE Pharmacy Connect
Educational Objectives
Review challenges that impact optimal treatment of skin barrier dysfunction in patients with acne who are seeking OTC care
List strategies to individualize patient care and improve recommendations for patients with acne experiencing skin barrier dysfunction
Faculty:
Robin Laird
Patient Advocate
Los Angeles, California
Mary Barna Bridgeman, PharmD, BCPS, BCGP
Clinical
Challenges in Treatment of Desmoid Tumors and Managed Care Solutions | PTCE Pharmacy Connect
Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.
Title: Challenges in Treatment of Desmoid Tumors and Managed Care Solutions
Ed
Examining Patient Burden in Atopic Dermatitis: Understanding Treatment Barriers and Optimal Use of OTC Skin Care Products, featuring a Caregiver Perspective | PTCE Pharmacy Connect
To claim CE credit for this activity, please follow this link: www.pharmacytimes.org/atopic-derm-podcast-630
Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailore
Continuing the Conversation: A Review of Targeted Therapies for Early-Stage Breast Cancer | PTCE Pharmacy Connect
Educational Objectives
Outline the place in therapy for targeted therapies based on patient-specific factors and subtype of early-stage breast cancer
Recognize methods to improve patient treatment selection while mitigating toxicities in patients with early-stage breast cancer
Faculty:
Allison R. Butts, PharmD, BCOP
Pharmacist Manager, Oncology
Breast Oncology Clinical Pharmacy Specialist
Acute C
Treatment of Duchenne Muscular Dystrophy: Updates in Disease-Modifying Drugs | PTCE Pharmacy Connect
Educational Objectives
Recall the pathophysiology and clinical manifestations of Duchenne muscular dystrophy (DMD), as well as the burden of DMD and its impact on patient quality of life
List the latest updates for the safety and efficacy data of new and approved disease-modifying therapies in the treatment of DMD
Faculty:
Amanda Hickman, PharmD, MPH, MSCS
Central Support Pharmacist – Neuro/Psy
Exploring the Emerging Treatment Landscape of Relapsed/Refractory Diffuse Large B-Cell | PTCE Pharmacy Connect
Educational Objective:
Outline various challenges and uncertainties affecting the optimization of treatment with novel immunotherapeutic modalities for relapsed/refractory diffuse large B-cell lymphoma.
Faculty:
Victoria Nachar, PharmD, BCOP
Clinical Pharmacist Specialist - Hematology
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan
Moderator:
Laura R. Bobolts, PharmD, BCOP
SVP
Advances in the Treatment of Immune Thrombocytopenia: Strategies for Optimizing Clinical and Patient Outcomes | PTCE Pharmacy Connect
Educational Objectives
Outline current guideline recommendations and strategies pharmacists can implement for the management of immune thrombocytopenia (ITP)
Recall the efficacy and safety of emerging agents for the treatment of ITP
Moderator:
Anthony J. Perissinotti, PharmD, BCOP
To claim CE credit for this activity, please visit the link below:
https://www.pharmacytimes.org/courses/advances-
Treatment Advancements in Atopic Dermatitis With JAK Inhibitors: Updates for Pharmacists | PTCE Pharmacy Connect
The educational objectives are:
• Review the pathophysiology of atopic dermatitis (AD) as well as the efficacy and safety data for topical JAK inhibitors that are approved and in development
• Discuss the role of pharmacists as a part of the care team for patients with AD as well as the key counseling points and monitoring parameters
Faculty: Dennis Williams
Moderator: Jamie McConaha
Continuing the Conversation: Exploring B-cell Maturation Antigen-Targeted Therapies and Managed Care Considerations for Patients With Multiple Myeloma | PTCE Pharmacy Connect
Educational Objectives
Discuss the differing classes of B-cell maturation antigen-directed therapy for multiple myeloma
Study the economic burden of multiple myeloma and cost-effective treatment strategies for B-cell maturation antigen-directed treatments
Faculty:
Joseph A. Kalis, PharmD, BCOP
Ambulatory Oncology Pharmacist
UCHealth Hematology/Oncology
Colorado Springs, Colorado
Scott A. Soefje
Treatment Advancements in Anemia in Chronic Kidney Disease: Assessing HIF-PH Inhibitors | PTCE Pharmacy Connect
Introduction of moderator, faculty, and disclosures by Todd:
We have an incredible discussion coming up with our moderator, Dr. Jessica Kerr, Professor and Clinical Pharmacy Specialist – Cardiometabolic at the Southern Illinois University Edwardsville School of Pharmacy in Illinois and Dr. Joanna Hudson, who is a tenured Professor in the Department of Clinical Pharmacy and Translational Science
Caring for Patients With Multiple Myeloma Through Pharmacist-Directed Supportive Care and Toxicity Management Strategies | PTCE Pharmacy Connect
Introduction of faculty and disclosures:
Dr. Kathryn Maples is a clinical pharmacy specialist in multiple myeloma at the Winship Cancer Institute with Emory Healthcare in Atlanta, Georgia.
Dr. Maples has the following relevant financial relationships with commercial interests to disclose: consultant for GlaxoSmithKline, Janssen, Karyopharm, and Sanofi.
Accreditation and support statement:
PT
The Managed Care Implications of Cost, Disease Burden, and Quality of Life in Myelofibrosis | PTCE Pharmacy Connect
Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.
The Managed Care Implications of Cost, Disease Burden, and Quality of Life in M
Achieving Treatment Goals in Myelofibrosis with JAK Inhibitors and Emerging Therapies | PTCE Pharmacy Connect
Educational Objective: Outline the standard treatment options for myelofibrosis as well as review clinical data for Janus kinase inhibitors and emerging targeted therapies.
Victoria Nachar, PharmD, BCOP
Clinical Pharmacist Specialist, Hematology
University of Michigan Rogel Cancer Center
Clinical Assistant Professor
University of Michigan College of Pharmacy
Ann Arbor, Michigan
Victoria Na
Setting the Scene in Myelofibrosis Treatment and Management | PTCE Pharmacy Connect
Educational Objective: Review the etiology and pathophysiology of myelofibrosis, including the World Health Organization classification and diagnostic criteria.
Victoria Nachar, PharmD, BCOP
Clinical Pharmacist Specialist, Hematology
University of Michigan Rogel Cancer Center
Clinical Assistant Professor
University of Michigan College of Pharmacy
Ann Arbor, Michigan
Victoria Nachar, PharmD,
Use of Novel Therapies in Endometrial Cancer: Update for Managed Care | PTCE Pharmacy Connect
Accreditation and support statement:
· PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.
· This activity is supported by educational grant from GlaxoSmithKline.
Objectives
• Review the guideline-recommended role of immune-based therapies in th
HIV Preexposure Prophylaxis (PrEP): Exploring the Current and Emerging Landscape | PTCE Pharmacy Connect
Educational Objectives
· Discuss currently available options for pre-exposure prophylaxis (PrEP) in the prevention of HIV.
· Describe the role of pharmacists in improving PrEP uptake in the United States.
Faculty:
Drew W. Cates, PharmD, AAHIVP,
Educational Manager
SynerGrx
Chamblee, Georgia
Faculty, has the following financial relationships with commercial interests to disclose:
Multiple Myeloma: Pharmacists as Therapy Experts | PTCE Pharmacy Connect
Educational Objectives
Objective 1: Describe a strategy to mitigate potential adverse effects of MM therapies by altering the route of administration, dosing schedule, and use of supportive care medications
Kathryn Maples, PharmD, BCOP
Clinical Pharmacy Specialist, Multiple Myeloma
Winship Cancer Institute, Emory Healthcare
Atlanta, Georgia
Kathryn Maples, PharmD, BCOP, has the following rele
Examining the Treatment Landscape of Metastatic NSCLC Expressing the Targetable Mutations RET, MET, and KRAS | PTCE Pharmacy Connect
Educational Objectives
• Review the targetable mutations RET, MET, and KRAS, including associated agents for the treatment of metastatic non-small cell lung cancer (NSCLC)
• Discuss the ways a pharmacist may improve adherence, toxicity management, and outcomes for patients with metastatic NSCLC expressing RET, MET, and KRAS mutations
Josiah D. Land, PharmD, BCOP
Clinical Pharmacy Specialist – Th
Continuing the Conversation: Optimizing Frontline Immunotherapy Outcomes in NSCLC and Managed Care Considerations | PTCE Pharmacy Connect
Educational Objectives
· Review the efficacy and safety of emerging frontline immune checkpoint inhibitor (ICI) used as monotherapy and in combination regimens
· Indicate the impact of ICIs and programmed death-ligand 1 testing on cost-effectiveness and patient reported outcomes related with frontline use of ICIs in advanced NSCLC
Faculty:
Paul Forsberg, PharmD, MHA, BCOP
Director of P
Caring for Patients With Multiple Myeloma Through Pharmacist-Directed Supportive Care and Toxicity Management Strategies | PTCE Pharmacy Connect
Introduction of faculty and disclosures:
Dr. Kathryn Maples is a clinical pharmacy specialist in multiple myeloma at the Winship Cancer Institute with Emory Healthcare in Atlanta, Georgia.
Dr. Maples has the following relevant financial relationships with commercial interests to disclose: consultant for GlaxoSmithKline, Janssen, Karyopharm, and Sanofi.
Accreditation and support statement:
PT
The Latest Advances in the Management of Atopic Dermatitis and the Role of JAK Inhibitors: Best Practices for the Pharmacist | PTCE Pharmacy Connect
Educational Objectives
· Understand the impact of Janus kinase inhibitors for the management of atopic dermatitis (AD)
· Examine key safety and efficacy data on new and emerging Janus kinase inhibitors utilized for the treatment of AD and select appropriate treatments
Identify the role of the pharmacist in individualizing treatment for patients with AD through patient counseling and educ
Continuing the Conversation | Optimizing Care for Patients With Endometrial Cancer: A Focus on Pharmacist Interventions and Mitigation of Health Equit...
Educational Objectives
· Recognize the role of biomarker expression in the selection of most appropriate treatment options for patients with endometrial cancer
· Review strategies for identification and management of drug-related toxicities in patients receiving therapy with immune checkpoint inhibitors, targeted agents, or combination therapy
Faculty:
Sarah Hayward, PharmD, BCOP
Clin
Understanding Chronic Lymphocytic Leukemia Drug Therapies | PTCE Pharmacy Connect
Introduction of faculty and disclosures:
Dr. Katherine Tobon is a clinical pharmacy specialist in malignant hematology with Moffitt Cancer Center in Tampa, Florida.
Dr. Tobon has no relevant financial relationships with commercial interests to disclose.
Accreditation and support statement:
PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continui
The Role of JAK Inhibitors in the Management of Atopic Dermatitis
This podcast will specifically focus on clinical safety and efficacy data supporting the use of new and emerging JAK inhibitors in the management of AD. Practical counseling points for pharmacists to provide individualized care and proper selection of therapy to patients with AD who are initiating therapy with JAK inhibitors will also be discussed. Faculty experts will review audience questions an
Chronic Lymphocytic Leukemia: Insights into the Pharmacist Role in Therapy Management
Introduction of faculty and disclosures:
Dr. Katherine Tobon is a clinical pharmacy specialist in malignant hematology with Moffitt Cancer Center in Tampa, Florida.
Dr. Tobon has no relevant financial relationships with commercial interests to disclose.
Accreditation and support statement:
PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continui
Where Are We Now?: The Changing Role of Pharmacists in the COVID-19 Treatment Landscape | PTCE Connect Podcast
Lisa Dumkow, PharmD, BCIDP, Antimicrobial Stewardship Clinical Pharmacist, PGY-2 Infectious Diseases Pharmacy Residency Program Director, Mercy Health Saint Mary’s, Grand Rapids, MI
Lacy Worden, PharmD, PGY-2 Infectious Diseases Pharmacy resident, Mercy Health Saint Mary’s, Grand Rapids MI [LP1]
Dr. Dumkow & Dr. Worden have no relevant financial relationships with commercial interests to disclos
Seizure Clusters: A Review of New Drug Delivery Methods and Emerging Therapy Options | PTCE Pharmacy Connect
Educational Objectives
Examine challenges in current treatment options for seizure clusters, including efficacy and safety, and differentiating routes of administration
Highlight considerations in treatment of seizure clusters, including addressing barriers to treatment and providing patient counseling to improve outcomes
Faculty:
Gretchen M. Brophy, PharmD, BCPS, FCCP, FCCM, FCCM, FNCS, MCCM
Novel Non-stimulant ADHD Treatments: A Review for Pharmacists | PTCE Pharmacy Connect
Educational Objectives
Describe the impact of ADHD and new non-stimulant class of ADHD treatments
Highlight the role of the pharmacist in patient counseling, monitoring and medication management in ADHD
Faculty:
Sandy Mullen, PharmD, BCPP
Clinical Pharmacy Specialist - Child and Adolescent Psychiatry
Department of Pharmacy
Virginia Commonwealth University (VCU) Health
Richmond, VA
Sandy Mul
Treatment and Management of ATTR: Understanding Small Interfering RNA and Emerging Therapies in the Treatment Landscape | PTCE Pharmacy Connect
Educational Objectives
•Review the clinical and economic burdens associated with transthyretin amyloidosis (ATTR)
•Recall key characteristics supporting the use of current and emerging therapies for the treatment of ATTR including mechanisms of action, clinical data, dosing, administration, and potential adverse effects
Faculty:
Svetlana Goldman, PharmD, BCACP, CDCES
Clinical Pharmacist
UC Davis
New and Emerging Non-Opioid Treatment Strategies for Pain Management: An Update for Pharmacists | PTCE Pharmacy Connect
Educational Objectives
Describe the impact of COVID-19 on surgical pain management
Review current postoperative pain management guidelines and emerging non-opioid treatment approaches for pain management, including safety and efficacy data on newer treatments, and key considerations for pharmacists
Faculty:
Jawad N. Saleh, PharmD, BS, BCPS, BCCCP
Clinical Manager of Pharmacy Services
Pharmacy
The Promising Role of Microbiome-Based Drugs for the Treatment and Prevention of Recurrent Clostridioides Difficile | PTCE Pharmacy Connect
Educational Objectives
Discuss the role of disruptions in the gut microbiome in the development of Clostridioides difficile infection (CDI) and recurrent CDIs
Review the efficacy, safety, and role of fecal microbiota transplantation and emerging microbiome-based drugs for treatment of CDIs and rCDIs
Faculty:
Kevin W. Garey, PharmD, MS
Professor and Chair
University of Houston College of Pharma
Proactive Management of Adverse Effects Associated With Waldenström Macroglobulinemia | PTCE Pharmacy Connect
Educational Objective
Identify best practices for managing toxicities associated with therapies for the treatment of Waldenström macroglobulinemia
Faculty: Victoria Nachar, PharmD, BCOP
Clinical Pharmacist Specialist, Ambulatory Hematology Oncology
University of Michigan Rogel Cancer Center
Clinical Assistant Professor
University of Michigan College of Pharmacy
Ann Arbor, Michigan
Faculty has n
Strategies for Pharmacist Involvement in Adverse Effect Management | PTCE Pharmacy Connect
Educational Objectives
· Recognize best practices for managing adverse effects associated with immune checkpoint inhibitor (ICI)-targeted therapy combinations
Faculty:
Jacob K. Kettle, PharmD, BCOP
Pharmacy Manager
Ellis Fischel Cancer Center
Department of Pharmacy
University of Missouri Health Care
Columbia, Missouri
Faculty, has the following financial relationships with commercia
Establishing the Role of Targeted Therapies in Cancer Care | PTCE Pharmacy Connect
Educational Objectives
· Describe the role of immune checkpoint inhibitor (ICI)-targeted therapy combinations across malignancies
· Recall knowledge of ICI-targeted therapy combinations to treatment selection in patients with cancer
Faculty:
Jacob K. Kettle, PharmD, BCOP
Pharmacy Manager
Ellis Fischel Cancer Center
Department of Pharmacy
University of Missouri Health Care
Waldenström Macroglobulinemia and Treatment Advancements with the Use of BTK Inhibitors | PTCE Pharmacy Connect
Pharmacy Times Continuing Education™ (PTCE) provides industry-leading pharmacy CE to retail, oncology, managed care, specialty, and health-system pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.
Podcast 1: Waldenström Macroglobulinemia and Treatment Advancements with the Us
Optimizing Care for People Living with HIV: Beyond Typical Risk Factors for Weight Gain | PTCE Pharmacy Connect
Optimizing Care for People Living with HIV: Beyond Typical Risk Factors for Weight Gain | PTCE Connect Educational Objectives Describe recent data surrounding weight gain among people living with HIV (PLWH) who are on antiretroviral therapy Recognize the role of the pharmacist in the care of PLWH Continuing the Conversation – Individualizing the Management of HIV: A Focus on Weight Gain Introducti
The Impact of COVID-19 Vaccine Hesitancy and Overcoming Patient Barriers | PTCE Connect
Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.
Educational Objectives:
Discuss the various barriers to COVID-19 vaccine uptake
Adverse Effects versus Convenience of the COVID-19 Viral-Vector Vaccines | PTCE Connect
Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.
Adverse Effects versus Convenience of the COVID-19 Viral-Vector Vaccines
Educat
Implementing Digital Technology Tools within Health-Systems for Improving Adherence and Patient Support | PTCE Pharmacy Connect
Implementing Digital Technology Tools within Health-Systems for Improving Adherence and Patient Support
Educational Objectives:
At the completion of this activity, participants will be able to:
Define the pharmacist’s role in implementing digital and telemedicine technologies within the health system to improve adherence and provide remote patient monitoring and management.
Anthony J. Perissinot
Optimizing Safety & Efficacy of BTK Inhibitors | PTCE Pharmacy Connect
Foundations of Evidence for the Use of BTK Inhibitors in B-Cell Malignancies and Management Strategies for Cardiac and Bleeding Adverse Effects
Educational Objectives:
At the completion of this activity, participants will be able to:
Outline the efficacy of oral BTK inhibitors across B-cell malignancies including a focus on emerging clinical data
Recognize pharmacists’ responsibilities for monito
Continuous Glucose Monitors in Diabetes Management | PTCE Pharmacy Connect
Continuous Glucose Monitoring:Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes in Diabetes Management
Objectives
Describe the use of continuous glucose monitoring (CGM) in diabetes management and ADA/AACE recommendations
Recognize the role of the pharmacist in providing education related to the use of CGM devices and interpreting CGM data
Faculty Disclosures
Cu
PCSK9 Inhibitors | Pharmacy Connect Podcast
Pharmacy Connect Podcast: PCSK9 Inhibitors
Title: PCSK9 Inhibitors:Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes With Hyperlipidemia Management
Special guest: Joseph Saseen, PharmD
Professor and Vice Chair, Clinical and Academic Programs; Department of Clinical Pharmacy
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorad
Recommended
1-2-3 Learn Spanish with Me!
128 Civics Questions for U.S. Citizenship Test
12 Hour Sound Machines for Sleep (no loops or fades)
#12minconvos
12 Minute Meditation
13 Again
1440 Explores
1490 Doom - Lore Series Podcast
15 MINS OF FAME
15 Minute Mysteries: The Deep Dive
15 minutes de grâce et de vérité
15 Minutes of Infamy
